Add Company
Join Now

Probiotec Revenue and Competitors

License our Company Data API

Laverton North, AU

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Probiotec's estimated annual revenue is currently $31M per year.(i)
  • Probiotec's estimated revenue per employee is $201,000

Employee Data

  • Probiotec has 154 Employees.(i)
  • Probiotec grew their employee count by 4% last year.

Probiotec's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Financial OfficerReveal Email/Phone
3
Chief Operating OfficerReveal Email/Phone
4
Chief People Officer - CPOReveal Email/Phone
5
Technical ManagerReveal Email/Phone
6
Quality Assurance ManagerReveal Email/Phone
7
Production ManagerReveal Email/Phone
8
Planning and Project ManagerReveal Email/Phone
9
Microbiology co-ordinatorReveal Email/Phone
10
General Manager Business DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$62.9M3138%N/AN/A
#2
$26.5M1327%N/AN/A
#3
$20.5M1020%N/AN/A
#4
$18.3M916%N/AN/A
#5
$18.7M932%N/AN/A
#6
$72.2M3596%N/AN/A
#7
$55.3M2756%N/AN/A
#8
$35.8M1786%N/AN/A
#9
$31M1544%N/AN/A
#10
$70.8M3525%N/AN/A
Add Company

What Is Probiotec?

Since beginning operations in 1997, Probiotec has quickly emerged as a leading manufacturer, marketer and distributer of a diverse, high quality range of prescription and over-the-counter (OTC) pharmaceuticals, complementary medicines and specialty ingredients. Now listed on the Australian Stock Exchange (ASX), this Australian owned and internationally operated company has built an enviable reputation for developing innovative new pharmaceutical, nutraceutical and cosmeceutical products which not only address researched consumer needs, but also succeed in gaining the clinical approvals necessary to respond rapidly to market opportunities, both locally and internationally. Product development, export, branded products

keywords:N/A

N/A

Total Funding

154

Number of Employees

$31M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Probiotec News

2022-03-30 - Does Probiotec (ASX:PBP) Deserve A Spot On Your Watchlist?

While we note Probiotec's EBIT margins were flat over the last year, revenue grew by a solid 54% to AU$163m. That's a real positive. In the...

2022-03-22 - This Insider Has Just Sold Shares In Probiotec Limited (ASX:PBP)

Probiotec Insider Transactions Over The Last Year. Notably, that recent sale by Wesley Stringer is the biggest insider sale of Probiotec shares...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$62.8M1748%N/A
#2
$15M2275%N/A